Signpath Pharma Competitors and Similar CompaniesClear all
Omeros's competitors and similar companies include CureVac.
 Omeros Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers. | ||
Founding Date | Founding Date 1994 | Founding Date 2000 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Seattle, US HQ | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US |
Employees | Employees 1968% decrease | Employees 82517% decrease |
Valuation ($) | Valuation ($) 248.6 m | Valuation ($) 648.3 m |
Financial | ||
Net income | Net income ($3.4m) (FY, 2025) | Net income €162.2m (FY, 2024) |
Operating ⚠ | ||
Phase I Trials Products | Phase I Trials Products 3 (FY, 2021) | Phase I Trials Products 3 (May, 2020) |
Funding | ||
Total funding raised | Total funding raised $ 354.8m | Total funding raised $ 1.1b |
For sources of this data, please see the company profile
View Company Profiles
CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View company